Aug 19, 2026 11:23AM
Aug 19, 2026 09:12AM
Jul 29, 2026 06:47AM
Jul 29, 2026 05:35AM
Jul 28, 2026 07:11AM
Jul 23, 2026 07:25AM
Jul 22, 2026 06:00AM Repligen to acquire BioLife Solutions for ~$1.5B
Jul 7, 2026 06:26AM
Jun 1, 2026 04:29PM
Jun 1, 2026 07:26AM
May 14, 2026 04:26PM
May 5, 2026 07:12AM
Apr 17, 2026 07:31AM
Apr 17, 2026 03:28AM Rothschild Redburn Starts Repligen (RGEN) at Buy
Mar 23, 2026 06:44AM
Mar 20, 2026 06:05AM
Feb 25, 2026 08:32AM
Feb 24, 2026 07:36AM
Jan 16, 2026 09:37AM
Jan 8, 2026 09:30AM
Jan 6, 2026 07:31AM Repligen names Dr. Martin Madaus as board chair as Tony Hunt retires
Dec 16, 2025 07:30AM
Dec 8, 2025 07:11AM
Nov 12, 2025 08:43AM
Oct 28, 2025 01:41PM
Oct 28, 2025 07:33AM
Oct 1, 2025 03:55AM
Sep 23, 2025 07:29AM KeyBanc Takeaways from This Year's BioProcess International Conference
Sep 23, 2025 07:26AM
Sep 22, 2025 06:02AM
Sep 17, 2025 07:53AM
Sep 16, 2025 08:39AM
Sep 11, 2025 04:06PM
Sep 3, 2025 06:47AM
Jul 30, 2025 08:47AM KeyBanc Reiterates Overweight Rating on Repligen (RGEN)
Jul 29, 2025 07:32AM
Jun 24, 2025 06:18AM
Jun 16, 2025 08:02AM
Jun 9, 2025 03:28PM
May 30, 2025 12:34PM
Apr 29, 2025 04:03PM
Apr 29, 2025 03:58PM Repligen (RGEN) PT Lowered to $914 at Jefferies
Apr 29, 2025 02:54PM
Apr 29, 2025 07:33AM
Mar 17, 2025 04:05PM
Mar 4, 2025 09:50AM
Mar 4, 2025 07:32AM
Feb 28, 2025 10:02AM
Feb 24, 2025 08:42AM Benchmark Reiterates Hold Rating on Repligen (RGEN)
Feb 21, 2025 06:46AM

456,975 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All